Menglu Fan

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

LncRNA ckATP1A1-AS1 inhibits influenza A virus replication by mediating innate immune responses and suppressing viral nuclear import.

LncRNA ckATP1A1-AS1 inhibits influenza A virus replication by mediating innate immune responses and suppressing viral nuclear import.

Journal: Journal of virology

Published: July 24, 2026

Gga-miR-92-targeted TNFRSF1B inhibits the replication of influenza A virus by degrading TRAF3.

Gga-miR-92-targeted TNFRSF1B inhibits the replication of influenza A virus by degrading TRAF3.

Journal: Journal of virology

Published: June 12, 2026

Transcriptome screening identifies circRNA-INSR as a novel host factor associated with avian influenza virus replication.

Transcriptome screening identifies circRNA-INSR as a novel host factor associated with avian influenza virus replication.

Journal: Virology

Published: May 20, 2026

CircZFYVE1 functions as a competitive endogenous RNA to enhance LSM14A-mediated antiviral defense against influenza A virus.

CircZFYVE1 functions as a competitive endogenous RNA to enhance LSM14A-mediated antiviral defense against influenza A virus.

Journal: Frontiers in immunology

Published: March 29, 2026

Gga-miR-449c suppresses H9N2 influenza virus replication via targeting the viral genome and suppressor of cytokine signaling 3.

Gga-miR-449c suppresses H9N2 influenza virus replication via targeting the viral genome and suppressor of cytokine signaling 3.

Journal: International journal of biological macromolecules

Published: December 16, 2025

CircMYO9A inhibits influenza A virus replication by dampening haemagglutinin cleavage via increasing SERPINE1/PAI-1 expression.

CircMYO9A inhibits influenza A virus replication by dampening haemagglutinin cleavage via increasing SERPINE1/PAI-1 expression.

Journal: Emerging microbes & infections

Published: May 02, 2025

PB2 627V and HA 217 sites synergistically affect the lethality of H9N2 in mice.

PB2 627V and HA 217 sites synergistically affect the lethality of H9N2 in mice.

Journal: Virologica Sinica

Published: September 15, 2024

Effects of the Glycosylation of the HA Protein of H9N2 Subtype Avian Influenza Virus on the Pathogenicity in Mice and Antigenicity.

Effects of the Glycosylation of the HA Protein of H9N2 Subtype Avian Influenza Virus on the Pathogenicity in Mice and Antigenicity.

Journal: Transboundary and emerging diseases

Published: December 16, 2023

Mutations of 127, 183 and 212 residues on the HA globular head affect the antigenicity, replication and pathogenicity of H9N2 avian influenza virus.

Mutations of 127, 183 and 212 residues on the HA globular head affect the antigenicity, replication and pathogenicity of H9N2 avian influenza virus.

Journal: Transboundary and emerging diseases

Published: May 06, 2021

Evolution of the PB1 gene of human influenza A (H3N2) viruses circulating between 1968 and 2019.

Evolution of the PB1 gene of human influenza A (H3N2) viruses circulating between 1968 and 2019.

Journal: Transboundary and emerging diseases

Published: April 26, 2021

Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus.

Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus.

Journal: Virology journal

Published: October 22, 2020

Analysis of the circRNAs expression profile in mouse lung with H7N9 influenza A virus infection.

Analysis of the circRNAs expression profile in mouse lung with H7N9 influenza A virus infection.

Journal: Genomics

Published: May 24, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026